Reforms to FDA Requirements for Cell and Gene Therapy Products
On January 11, 2026, the FDA issued two news releases putting forward reforms to the chemistry, manufacturing, and control requirements for cell and gene therapy products, one titled FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation and the other titled Flexible Requirements for Cell and … Continue reading Reforms to FDA Requirements for Cell and Gene Therapy Products
